VCID: 31477
Profile

Corporate information

Investment activity status
Active investor

Selected investments

Country Date Notes
Aderis Pharmaceuticals Inc
Novel small molecule, receptor-specific therapeutics company for the treatment of central nervous system, cardiovascular and renal diseases. 		United States 9 Oct 2001 Series D
Initial investment. Round participant. Active

DISCLAIMER: This chart is based on a limited amount of data and may change once additional information has been added. We are working hard to ensure the completeness of the data. If you want to assist us in our work, please contact us using this form.